Cardiovascular Systems shares steady on Q4, FY2018 earnings beat
Shares in Cardiovascular Systems (NSDQ:CSII) have stayed steady in after-hours trading after the medical device maker posted full year and fourth quarter fiscal year 2018 earnings that beat expectations on Wall Street.
The St. Paul, Minn.-based company posted profits of $3.7 million, or 11¢ per share, on sales of $59.2 million for the three months June 30, seeing massive 384.1% growth on the bottom-line while sales grew 11.8% compared with the same period during the previous year.
Earnings per share beat the 6¢ expectations on Wall Street, where analysts expected too see sales of $58.2 million, which the company also topped.
For the full year, Cardiovascular Systems posted profits of $1.7 million, or 5¢ per share, on sales of $217 million, seeing a nearly 200% turn from red on the bottom-line while sales grew 5.9% compared with the previous fiscal year.
Earnings per share beat the null consensus on Wall Street, where analysts expected to see sales of $216 million, which the company topped.
“We are driving strong growth and market-leading performance in our coronary and peripheral atherectomy businesses through strong sales execution in the United States, new product introductions and the launch of our business in Japan. We successfully delivered annual revenue growth and our first annual net profit despite experiencing temporary business disruptions early in fiscal 2018. Throughout the year, we remained focused on fulfilling our mission to serve patients suffering f...
Source: Mass Device - Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat Cardiovascular Systems Inc. Source Type: news
More News: Cardiology | Cardiovascular | Heart | Japan Health | Medical Devices | Peripheral Vascular Disease (PVD) | Profits and Losses | USA Health